350 related articles for article (PubMed ID: 33810109)
1. Cystic Fibrosis-Related Diabetes (CFRD): Overview of Associated Genetic Factors.
Iafusco F; Maione G; Rosanio FM; Mozzillo E; Franzese A; Tinto N
Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33810109
[TBL] [Abstract][Full Text] [Related]
2. Cystic Fibrosis-Related Diabetes: Pathophysiology and Therapeutic Challenges.
Kelsey R; Manderson Koivula FN; McClenaghan NH; Kelly C
Clin Med Insights Endocrinol Diabetes; 2019; 12():1179551419851770. PubMed ID: 31191067
[TBL] [Abstract][Full Text] [Related]
3. Management of endocrine disease: Cystic fibrosis-related diabetes: novel pathogenic insights opening new therapeutic avenues.
Barrio R
Eur J Endocrinol; 2015 Apr; 172(4):R131-41. PubMed ID: 25336504
[TBL] [Abstract][Full Text] [Related]
4. The Potential Causes of Cystic Fibrosis-Related Diabetes.
Coderre L; Debieche L; Plourde J; Rabasa-Lhoret R; Lesage S
Front Endocrinol (Lausanne); 2021; 12():702823. PubMed ID: 34394004
[TBL] [Abstract][Full Text] [Related]
5. Islet-intrinsic effects of CFTR mutation.
Koivula FNM; McClenaghan NH; Harper AGS; Kelly C
Diabetologia; 2016 Jul; 59(7):1350-1355. PubMed ID: 27033560
[TBL] [Abstract][Full Text] [Related]
6. New Concepts in the Pathogenesis of Cystic Fibrosis-Related Diabetes.
Moheet A; Moran A
J Clin Endocrinol Metab; 2022 May; 107(6):1503-1509. PubMed ID: 35106591
[TBL] [Abstract][Full Text] [Related]
7. Pancreas and islet morphology in cystic fibrosis: clues to the etiology of cystic fibrosis-related diabetes.
Malik SS; Padmanabhan D; Hull-Meichle RL
Front Endocrinol (Lausanne); 2023; 14():1269139. PubMed ID: 38075070
[TBL] [Abstract][Full Text] [Related]
8. Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.
Putman MS; Norris AW; Hull RL; Rickels MR; Sussel L; Blackman SM; Chan CL; Ode KL; Daley T; Stecenko AA; Moran A; Helmick MJ; Cray S; Alvarez JA; Stallings VA; Tuggle KL; Clancy JP; Eggerman TL; Engelhardt JF; Kelly A
Diabetes Care; 2023 Jun; 46(6):1112-1123. PubMed ID: 37125948
[TBL] [Abstract][Full Text] [Related]
9. Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.
Putman MS; Norris AW; Hull RL; Rickels MR; Sussel L; Blackman SM; Chan CL; Ode KL; Daley T; Stecenko AA; Moran A; Helmick MJ; Cray S; Alvarez JA; Stallings VA; Tuggle KL; Clancy JP; Eggerman TL; Engelhardt JF; Kelly A
Diabetes; 2023 Jun; 72(6):677-689. PubMed ID: 37125945
[TBL] [Abstract][Full Text] [Related]
10. Islet Function in the Pathogenesis of Cystic Fibrosis-Related Diabetes Mellitus.
Westholm E; Wendt A; Eliasson L
Clin Med Insights Endocrinol Diabetes; 2021; 14():11795514211031204. PubMed ID: 34345195
[TBL] [Abstract][Full Text] [Related]
11. The effect of cystic fibrosis transmembrane conductance regulator modulators on impaired glucose tolerance and cystic fibrosis related diabetes.
Hasan S; Khan MS; Lansang MC
J Clin Transl Endocrinol; 2022 Sep; 29():100301. PubMed ID: 35746945
[TBL] [Abstract][Full Text] [Related]
12. Cystic Fibrosis-Related Diabetes.
Kayani K; Mohammed R; Mohiaddin H
Front Endocrinol (Lausanne); 2018; 9():20. PubMed ID: 29515516
[TBL] [Abstract][Full Text] [Related]
13. Evolving Mechanistic Views and Emerging Therapeutic Strategies for Cystic Fibrosis-Related Diabetes.
Yoon JC
J Endocr Soc; 2017 Nov; 1(11):1386-1400. PubMed ID: 29264462
[TBL] [Abstract][Full Text] [Related]
14. Understanding the Pancreatic Islet Microenvironment in Cystic Fibrosis and the Extrinsic Pathways Leading to Cystic Fibrosis Related Diabetes.
Al-Selwi Y; Shaw JA; Kattner N
Clin Med Insights Endocrinol Diabetes; 2021; 14():11795514211048813. PubMed ID: 34675737
[TBL] [Abstract][Full Text] [Related]
15. Cystic fibrosis-related diabetes is caused by islet loss and inflammation.
Hart NJ; Aramandla R; Poffenberger G; Fayolle C; Thames AH; Bautista A; Spigelman AF; Babon JAB; DeNicola ME; Dadi PK; Bush WS; Balamurugan AN; Brissova M; Dai C; Prasad N; Bottino R; Jacobson DA; Drumm ML; Kent SC; MacDonald PE; Powers AC
JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669939
[TBL] [Abstract][Full Text] [Related]
16. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
Winhofer Y; Wolf P; Fellinger P; Tura A; Hillebrand P; Staufer K; Trauner M; Jaksch P; Muraközy G; Kautzky-Willer A; Pacini G; Krebs M; Luger A; Kazemi-Shirazi L
Endocr Pract; 2019 Mar; 25(3):254-262. PubMed ID: 30913015
[TBL] [Abstract][Full Text] [Related]
17. Lumacaftor/ivacaftor therapy is associated with reduced hepatic steatosis in cystic fibrosis patients.
Kutney K; Donnola SB; Flask CA; Gubitosi-Klug R; O'Riordan M; McBennett K; Sferra TJ; Kaminski B
World J Hepatol; 2019 Dec; 11(12):761-772. PubMed ID: 31966908
[TBL] [Abstract][Full Text] [Related]
18. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
[TBL] [Abstract][Full Text] [Related]
19. The role of genetic modifiers, inflammation and CFTR in the pathogenesis of Cystic fibrosis related diabetes.
Hasan S; Soltman S; Wood C; Blackman SM
J Clin Transl Endocrinol; 2022 Mar; 27():100287. PubMed ID: 34976741
[TBL] [Abstract][Full Text] [Related]
20. CFTR silencing in pancreatic β-cells reveals a functional impact on glucose-stimulated insulin secretion and oxidative stress response.
Ntimbane T; Mailhot G; Spahis S; Rabasa-Lhoret R; Kleme ML; Melloul D; Brochiero E; Berthiaume Y; Levy E
Am J Physiol Endocrinol Metab; 2016 Feb; 310(3):E200-12. PubMed ID: 26625901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
